ZA921716B - Amide-chelates,their metal complexes as well as their use in diagnosis and treatment - Google Patents
Amide-chelates,their metal complexes as well as their use in diagnosis and treatmentInfo
- Publication number
- ZA921716B ZA921716B ZA921716A ZA921716A ZA921716B ZA 921716 B ZA921716 B ZA 921716B ZA 921716 A ZA921716 A ZA 921716A ZA 921716 A ZA921716 A ZA 921716A ZA 921716 B ZA921716 B ZA 921716B
- Authority
- ZA
- South Africa
- Prior art keywords
- chelates
- diagnosis
- amide
- treatment
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4107571A DE4107571A1 (de) | 1991-03-07 | 1991-03-07 | Amid-chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA921716B true ZA921716B (en) | 1992-11-25 |
Family
ID=6426850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA921716A ZA921716B (en) | 1991-03-07 | 1992-03-06 | Amide-chelates,their metal complexes as well as their use in diagnosis and treatment |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0502595A3 (pt) |
JP (1) | JPH06100519A (pt) |
AU (1) | AU1214892A (pt) |
CA (1) | CA2062454A1 (pt) |
DE (1) | DE4107571A1 (pt) |
IE (1) | IE920761A1 (pt) |
PT (1) | PT100200A (pt) |
ZA (1) | ZA921716B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6359120B1 (en) | 1991-10-29 | 2002-03-19 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia-localizing moiety |
US5808091A (en) * | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
EP0663900B1 (en) * | 1992-10-08 | 1999-09-22 | Nycomed Amersham PLC | Metal-oxime chelates for use as radiopharmaceutical agents |
US5608110A (en) * | 1993-06-15 | 1997-03-04 | Bracco International B.V. | Heteroatom-bearing ligands and metal complexes thereof |
DK0688313T3 (da) | 1994-01-12 | 1998-05-11 | Bracco Int Bv | Ligander og metalkomplekser deraf |
US6027890A (en) | 1996-01-23 | 2000-02-22 | Rapigene, Inc. | Methods and compositions for enhancing sensitivity in the analysis of biological-based assays |
US6312893B1 (en) | 1996-01-23 | 2001-11-06 | Qiagen Genomics, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
US6613508B1 (en) | 1996-01-23 | 2003-09-02 | Qiagen Genomics, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
KR100675356B1 (ko) * | 2005-04-29 | 2007-02-01 | 경희대학교 산학협력단 | 액체 또는 초임계상태의 유체를 이용하여 금속이온 및금속산화물을 추출하는 금속추출에 사용되는 신규한 아미드화합물을 포함하는 킬레이트제와 상기 킬레이트제를이용한 금속추출방법 및 금속추출시스템 |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0194843B1 (en) * | 1985-03-11 | 1993-01-13 | AMERSHAM INTERNATIONAL plc | Complexes of technetium-99m with propylene amine oximes |
US4746505A (en) * | 1985-04-26 | 1988-05-24 | President And Fellows Of Harvard College | Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands |
-
1991
- 1991-03-07 DE DE4107571A patent/DE4107571A1/de not_active Withdrawn
-
1992
- 1992-03-05 JP JP4048718A patent/JPH06100519A/ja active Pending
- 1992-03-05 PT PT100200A patent/PT100200A/pt not_active Application Discontinuation
- 1992-03-05 EP EP19920250052 patent/EP0502595A3/de not_active Withdrawn
- 1992-03-06 ZA ZA921716A patent/ZA921716B/xx unknown
- 1992-03-06 CA CA002062454A patent/CA2062454A1/en not_active Abandoned
- 1992-03-06 AU AU12148/92A patent/AU1214892A/en not_active Abandoned
- 1992-03-09 IE IE076192A patent/IE920761A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0502595A3 (en) | 1993-08-11 |
CA2062454A1 (en) | 1992-09-08 |
IE920761A1 (en) | 1992-09-09 |
EP0502595A2 (de) | 1992-09-09 |
AU1214892A (en) | 1992-09-10 |
JPH06100519A (ja) | 1994-04-12 |
PT100200A (pt) | 1993-05-31 |
DE4107571A1 (de) | 1992-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2252771B (en) | Platinum complexes and use thereof | |
EP0623020A4 (en) | PYROPHEOPHORBIDES AND THEIR USE IN PHOTODYNAMIC THERAPY. | |
AU4254696A (en) | Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy | |
EP0604433A4 (en) | Composition and method for disease treatment. | |
GB0204115D0 (en) | Metal complexes comprising A 2,6-Diacylpyride-ligand and their use in the polymerzation of ethylene | |
IL99612A0 (en) | 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy | |
EP0730449A4 (en) | NOVEL PALLADIUM COMPLEXES AND METHODS OF USE THEREOF IN THE TREATMENT OF TUMORS AND PSORIASIS | |
ZA921716B (en) | Amide-chelates,their metal complexes as well as their use in diagnosis and treatment | |
EP0612513A3 (en) | External skin treatment composition. | |
HK1001286A1 (en) | Benzopyrans and their use as therapeutic agents. | |
IL112602A0 (en) | N,n-dimethyl-1-Ú1-(4-chlorophenyl)cyclobutyl¾-3-methylbutylamine in the treatment of epilepsy | |
ZA935575B (en) | Therapeutic agent and its use. | |
ZA921717B (en) | Chelates,their metal complexes as well as their use in diagnosis and treatment | |
HUP9900449A3 (en) | Metal complexes of polyaminoacids, and their utilization in diagnostic imaging | |
ZA925892B (en) | Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases. | |
EP0706396A4 (en) | 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND THEIR USES | |
ZA922952B (en) | 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy | |
EP0381304A3 (en) | Use of dextran sulfate, possibly in combination with anti-androgenic agents, in the treatment of human carcinoma | |
ZA924127B (en) | New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents | |
EP0442086A3 (en) | Graftcopolymers, their preparation and their use | |
AU8174691A (en) | Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment | |
HU9600228D0 (en) | Radiometal complexes that localise in hypoxic tissue | |
HUT76806A (en) | Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents | |
GB9300912D0 (en) | Coordination complexes,preparation and use | |
IL87356A0 (en) | Streptogramine b/metal complexes,their preparation and use in livestock nutrition |